These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8933171)

  • 1. Inhibition of human eosinophil chemotaxis in vitro by the anti-allergic agent emedastine difumarate.
    el-Shazly AE; Masuyama K; Samejima Y; Eura M; Ishikawa T
    Immunopharmacol Immunotoxicol; 1996 Nov; 18(4):587-95. PubMed ID: 8933171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bepotastine besilate, a highly selective histamine H(1) receptor antagonist, suppresses vascular hyperpermeability and eosinophil recruitment in in vitro and in vivo experimental allergic conjunctivitis models.
    Kida T; Fujii A; Sakai O; Iemura M; Atsumi I; Wada T; Sakaki H
    Exp Eye Res; 2010 Jul; 91(1):85-91. PubMed ID: 20412793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of emedastine difumarate on CC chemokine-elicited eosinophil migration.
    Saito H; Yamamoto N; Tomita S; Taniguchi M; Hasegawa M; Akiyama K; Kawaguchi H; Takahashi K
    Int Arch Allergy Immunol; 2001; 125 Suppl 1():22-8. PubMed ID: 11408768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-activating factor (PAF)-induced chemotaxis and PAF binding to human eosinophils.
    Fukuda T; Numao T; Akutsu I; Makino S
    J Lipid Mediat; 1992; 5(2):145-9. PubMed ID: 1525356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of terfenadine on human eosinophil and neutrophil chemotactic response and generation of superoxide.
    Eda R; Townley RG; Hopp RJ
    Ann Allergy; 1994 Aug; 73(2):154-60. PubMed ID: 8067599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.
    Wardlaw AJ; Moqbel R; Cromwell O; Kay AB
    J Clin Invest; 1986 Dec; 78(6):1701-6. PubMed ID: 3023451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-allergic properties of the bromeliaceae Nidularium procerum: inhibition of eosinophil activation and influx.
    Vieira-de-Abreu A; Amendoeira FC; Gomes GS; Zanon C; Chedier LM; Figueiredo MR; Kaplan MA; Frutuoso VS; Castro-Faria-Neto HC; Weller PF; Bandeira-Melo C; Bozza PT
    Int Immunopharmacol; 2005 Dec; 5(13-14):1966-74. PubMed ID: 16275631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of glucocorticoids on rat eosinophil superoxide generation and chemotaxis.
    Sugimoto Y; Ogawa M; Tai N; Kamei C
    Int Immunopharmacol; 2003 Jun; 3(6):845-52. PubMed ID: 12781701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptides modulate human eosinophil chemotaxis.
    Numao T; Agrawal DK
    J Immunol; 1992 Nov; 149(10):3309-15. PubMed ID: 1385521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of anti-asthmatic drugs on human eosinophil chemotaxis].
    Numao T; Fukuda T; Akutsu I; Makino S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Jan; 29(1):65-71. PubMed ID: 1645817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-activating factor-induced human eosinophil transendothelial migration: evidence for a dynamic role of the endothelium.
    Casale TB; Erger RA; Little MM
    Am J Respir Cell Mol Biol; 1993 Jan; 8(1):77-82. PubMed ID: 8380250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triple role of platelet-activating factor in eosinophil migration across monolayers of lung epithelial cells: eosinophil chemoattractant and priming agent and epithelial cell activator.
    Liu L; Zuurbier AE; Mul FP; Verhoeven AJ; Lutter R; Knol EF; Roos D
    J Immunol; 1998 Sep; 161(6):3064-70. PubMed ID: 9743372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emedastine difumarate: a review of its potential ameliorating effect for tissue remodeling in allergic diseases.
    Murota H; Katayama I
    Expert Opin Pharmacother; 2009 Aug; 10(11):1859-67. PubMed ID: 19558341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histamine-induced adherence and migration of equine eosinophils.
    Foster AP; Cunningham FM
    Am J Vet Res; 1998 Sep; 59(9):1153-9. PubMed ID: 9736395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor alpha induces migration of human eosinophils.
    Nagata M; Fukuda T; Numao T; Makino S; Dohi Y
    Arerugi; 1993 Apr; 42(4):549-55. PubMed ID: 8323453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of a 1-week administration of cetirizine on the chemotaxis and superoxide anion production of neutrophils from healthy volunteers.
    Condino-Neto A; Muscara MN; Bozza PT; Castro-Faria-Neto HC; De Nucci G
    Int J Clin Pharmacol Ther; 1996 Mar; 34(3):96-100. PubMed ID: 8705094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RANTES is a chemotactic and activating factor for human eosinophils.
    Alam R; Stafford S; Forsythe P; Harrison R; Faubion D; Lett-Brown MA; Grant JA
    J Immunol; 1993 Apr; 150(8 Pt 1):3442-8. PubMed ID: 7682241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of platelet-activating factor (PAF)-induced chemotaxis and PAF binding to human eosinophils and neutrophils by the specific ginkgolide-derived PAF antagonist, BN 52021.
    Kurihara K; Wardlaw AJ; Moqbel R; Kay AB
    J Allergy Clin Immunol; 1989 Jan; 83(1):83-90. PubMed ID: 2536413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAF-induced eosinophil chemotaxis increases during an asthmatic attack and is inhibited by prednisolone in vivo and in vitro.
    Shindo K; Koide K; Fukumura M
    Biochem Biophys Res Commun; 1997 Aug; 237(1):146-51. PubMed ID: 9266847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of loratadine on human eosinophil function in vitro.
    Eda R; Sugiyama H; Hopp RJ; Bewtra AK; Townley RG
    Ann Allergy; 1993 Oct; 71(4):373-8. PubMed ID: 8214802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.